1. Argus-T Sling in 182 Male Patients: Short-term Results of a Multicenter Study.
- Author
-
Siracusano S, Visalli F, Favro M, Tallarigo C, Saccomanni M, Kugler A, Diminutto A, Talamini R, and Artibani W
- Subjects
- Aged, Aged, 80 and over, Humans, Male, Middle Aged, Prospective Studies, Severity of Illness Index, Time Factors, Treatment Outcome, Postoperative Complications surgery, Prostatectomy, Suburethral Slings, Urinary Incontinence surgery
- Abstract
Objective: To evaluate the short-term results with Argus-T sling in patients with post-prostatectomy incontinence (PPI)., Materials and Methods: A total of 182 patients with PPI were treated with Argus-T sling at 5 urologic centers from June 2008 to March 2013. The preoperative evaluation included medical history, pad count (1-2 pads: mild PPI; 3-5 pads: moderate PPI; >5 pads: severe PPI), visual analog scale on continence, quality of life score scale, physical examination, cystoscopy, and urodynamic evaluation. Postoperative evaluation was performed 6 weeks postoperatively, and late follow-up was achieved in April 2013. We considered a successful result when patients were cured (0-1 pads/24 hours) and or improved (1-2 pads/24 hours or a reduction in pad per day usage greater than 50%)., Results: Twenty-one (11.8%), 96 (52.7%), and 65 (35.7%) patients have mild, moderate, and severe incontinence, respectively. At the median follow-up of 22 months, the overall success rate was 86.2%. We obtained successful results of 95% in mild incontinence, 78% in moderate incontinence and 70% in severe incontinence. In cured and improved patients, we observed a statistically significant amelioration of quality of life (Pā<.0001). Sling regulation was carried out in 42.9% of cases, whereas its removal occurred in 9.3% of cases. Postoperative complications were reported in 14.3% of patients. In patients with previous radiotherapy, we observed a successful result in 61.2% of cases., Conclusion: This study represents the first report that shows short-term results of Argus-T positioning in a large population. Argus-T seems to offer good outcomes in patients with mild and moderate PPI., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF